Boston, MA, United States of America

Kameran Lashkari

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 176(Granted Patents)


Location History:

  • Natic, MA (US) (2015)
  • Boston, MA (US) (1998 - 2021)

Company Filing History:


Years Active: 1998-2021

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations of Kameran Lashkari in Ocular Health

Introduction

Kameran Lashkari is a notable inventor based in Boston, MA, who has made significant contributions to the field of ocular health. With a total of nine patents to his name, he has focused on developing innovative treatments for eye disorders, particularly age-related macular degeneration (AMD) and pathogenic ocular neovascularization.

Latest Patents

Lashkari's latest patents include groundbreaking applications directed at the use of VEGF-C inhibitors, VEGFR-2 inhibitors, and VEGFR-3 inhibitors as both prophylactic and therapeutic measures for treating eye disorders. His work emphasizes the importance of VEGF-C measurements from biological samples as predictive, selected, responsive, or tracking markers for diseases such as maculopathy and pathogenic ocular neovascularization. These innovations hold promise for improving diagnostic and treatment methodologies in ocular health.

Career Highlights

Throughout his career, Kameran Lashkari has worked with esteemed organizations, including the Schepens Eye Research Institute, Inc. His research has been pivotal in advancing the understanding and treatment of various eye conditions, showcasing his commitment to enhancing patient care through innovative solutions.

Collaborations

Lashkari has collaborated with notable colleagues such as Mark Harooni and Megan E. Baldwin, contributing to a dynamic research environment that fosters innovation and discovery in ocular health.

Conclusion

Kameran Lashkari's contributions to the field of ocular health through his patents and collaborations highlight his role as a leading inventor in the treatment of eye disorders. His work continues to pave the way for advancements in medical science, particularly in the realm of age-related macular degeneration and related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…